Biggest changeFY21 % Change North America $ 112,214 $ 98,527 $ 73,625 13.9 % 33.8 % Asia/Pacific 59,557 49,235 40,839 21.0 % 20.6 % Europe 62,017 64,435 52,549 (3.8 %) 22.6 % Latin America 28,924 12,439 9,651 132.5 % 28.9 % Other (1) (54 ) (16 ) 273 (237.5 %) (105.9 %) Total $ 262,658 $ 224,620 $ 176,937 16.9 % 26.9 % Gross profit by geographic area and percent of geographic net sales for fiscal 2023, fiscal 2022 and fiscal 2021 were as follows ( in thousands ): FY 2023 FY 2022 FY 2021 Gross Profit (Loss) Amount % of Net Sales Amount % of Net Sales Amount % of Net Sales North America $ 43,580 38.8 % $ 36,548 37.1 % $ 28,639 38.9 % Asia/Pacific 18,775 31.5 % 15,728 31.9 % 13,520 33.1 % Europe 18,760 30.2 % 19,215 29.8 % 16,958 32.3 % Latin America 7,735 26.7 % 4,340 34.9 % 3,405 35.3 % Other (1) (5,161 ) (4,131 ) (3,697 ) Total $ 83,689 31.9 % $ 71,700 31.9 % $ 58,825 33.2 % (1) Other primarily includes net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses. 25 We sell our products to customers in diversified industries and perform periodic credit evaluations of our customers’ financial condition.
Biggest changeFY22 % Change North America $ 77,269 $ 112,214 $ 98,527 (31.1 %) 13.9 % Asia/Pacific 45,264 59,557 49,235 (24.0 %) 21.0 % Europe 61,476 62,017 64,435 (0.9 %) (3.8 %) Latin America 10,908 28,924 12,439 (62.3 %) 132.5 % Other (1) 1,543 (54 ) (16 ) 2,957.4 % (237.5 %) Total $ 196,460 $ 262,658 $ 224,620 (25.2 %) 16.9 % (1) Primarily includes net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses. 26 Gross profit by geographic area and percent of geographic net sales for fiscal 2024, fiscal 2023 and fiscal 2022 were as follows ( in thousands ): FY 2024 FY 2023 FY 2022 Gross Profit (Loss) Amount % of Net Sales Amount % of Net Sales Amount % of Net Sales North America $ 29,306 37.9 % $ 43,580 38.8 % $ 36,548 37.1 % Asia/Pacific 13,682 30.2 % 18,775 31.5 % 15,728 31.9 % Europe 18,516 30.1 % 18,760 30.2 % 19,215 29.8 % Latin America 3,983 36.5 % 7,735 26.7 % 4,340 34.9 % Other (1) (5,521 ) (5,161 ) (4,131 ) Total $ 59,966 30.5 % $ 83,689 31.9 % $ 71,700 31.9 % (1) Primarily includes net sales not allocated to a specific geographical region, unabsorbed value-add costs and other unallocated expenses.
On March 20, 2023, the Company established a senior, secured revolving credit facility agreement with a three-year term in an aggregate principal amount not to exceed $30 million, including a Swingline Loan sub-facility and a Letter of Credit sub-facility (collectively, the "Revolving Credit Facility") with PNC Bank. The Revolving Credit Facility is guaranteed by the Company's domestic subsidiaries.
On March 20, 2023, the Company established a senior, secured revolving credit facility agreement with a three-year term in an aggregate principal amount not to exceed $30 million, including a swingline loan and a letter of credit sub-facility (collectively, the "Revolving Credit Facility") with PNC Bank. The Revolving Credit Facility is guaranteed by the Company's domestic subsidiaries.
Significant changes in one or more of these considerations may require adjustments affecting net income and net carrying value of accounts receivable. 30 Revenue Recognition Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit.
Significant changes in one or more of these considerations may require adjustments affecting net income and net carrying value of accounts receivable. Revenue Recognition Our customers are generally not resellers, but rather businesses that incorporate our products into their processes from which they generate an economic benefit.
The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers.
The goods we provide to our customers are distinct in that our customers benefit from the goods we sell them through use in their own processes. 31 Distribution typically includes products purchased from our suppliers, stocked in our warehouses and then sold to our customers.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to assist the reader in better understanding our business, results of operations, financial condition, changes in financial condition, critical accounting policies and estimates and significant developments.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to assist the reader in better understanding our business, results of operations, financial condition, changes in financial condition, critical accounting estimates and significant developments.
The difference between the effective income tax rates as compared to the U.S. federal statutory rate of 21.0% during fiscal 2023, fiscal 2022 and fiscal 2021 was primarily driven by the impact of valuation allowance changes related to the realizability of our U.S. state and federal net deferred tax assets and changes in our geographical distribution of income (loss).
The difference between the effective income tax rates as compared to the U.S. federal statutory rate of 21.0% during fiscal 2024, fiscal 2023 and fiscal 2022 was primarily driven by the impact of valuation allowance changes related to the realizability of our U.S. state and federal net deferred tax assets and changes in our geographical distribution of income (loss).
Our assumptions, judgments and estimates are based on historical experience and various other factors deemed relevant. Actual results could be materially different from those estimates under different assumptions or conditions. We evaluate our assumptions, judgments and estimates on a regular basis. We also discuss our critical policies and estimates with the Audit Committee of the Board of Directors.
Our assumptions, judgments and estimates are based on historical experience and various other factors deemed relevant. Actual results could be materially different from those estimates under different assumptions or conditions. We evaluate our assumptions, judgments and estimates on a regular basis. We also discuss our critical accounting estimates with the Audit Committee of the Board of Directors.
Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI coils, cold heads and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market.
Products include diagnostic imaging replacement parts for CT and MRI systems; replacement CT and MRI tubes; CT service training; MRI and RF amplifiers; hydrogen thyratrons, klystrons, magnetrons; flat panel detector upgrades; pre-owned CT systems; and additional replacement solutions currently under development for the diagnostic imaging service market.
This section is organized as follows: • Business Overview • Results of Operations - an analysis and comparison of our consolidated results of operations for the fiscal years ended May 27, 2023, May 28, 2022 and May 29, 2021, as reflected in our Consolidated Statements of Comprehensive Income. • Liquidity, Financial Position and Capital Resources - a discussion of our primary sources and uses of cash for the fiscal years ended May 27, 2023, May 28, 2022 and May 29, 2021, and a discussion of changes in our financial position.
This section is organized as follows: • Business Overview • Results of Operations - an analysis and comparison of our consolidated results of operations for the fiscal years ended June 1, 2024, May 27, 2023 and May 28, 2022, as reflected in our Consolidated Statements of Comprehensive Income. • Liquidity, Financial Position and Capital Resources - a discussion of our primary sources and uses of cash for the fiscal years ended June 1, 2024, May 27, 2023 and May 28, 2022, and a discussion of changes in our financial position.
Business Overview Richardson Electronics, Ltd. is a leading global manufacturer of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes and service training for diagnostic imaging equipment; and customized display solutions.
Business Overview Richardson Electronics, Ltd. (the "Company," "we," "our") is a leading global manufacturer of engineered solutions, power grid and microwave tubes and related consumables; power conversion and RF and microwave components; high-value replacement parts, tubes and service training for diagnostic imaging equipment; and customized display solutions.
The remaining valuation allowance relates to state NOLs ($0.2 million) and deferred tax assets in foreign jurisdictions where historical taxable losses have been incurred ($1.3 million).
The valuation allowance relates to state NOLs ($1.1 million) and deferred tax assets in foreign jurisdictions where historical taxable losses have been incurred ($1.0 million).
We believe the assumptions, judgments and estimates involved for the following have the greatest potential impact on our Consolidated Financial Statements: • Allowance for Doubtful Accounts • Revenue Recognition • Inventories, net • Intangible and Long-Lived Assets • Loss Contingences • Income Taxes Allowance for Doubtful Accounts Our allowance for doubtful accounts includes estimated losses that result from uncollectible receivables.
We believe the assumptions, judgments and estimates involved for the following have the greatest potential impact on our Consolidated Financial Statements: • Allowance for Credit Losses • Revenue Recognition • Inventories, net • Intangible and Long-Lived Assets • Income Taxes Allowance for Credit Losses Our allowance for credit losses includes estimated losses that result from uncollectible receivables.
Income taxes paid, including foreign estimated tax payments, were $4.8 million, $1.5 million and $0.1 million, during fiscal 2023, fiscal 2022 and fiscal 2021, respectively. In the normal course of business, we are subject to examination by taxing authorities throughout the world.
Income taxes paid, net of refunds, including foreign estimated tax payments, were less than $0.1 million, $4.8 million and $1.5 million, during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. In the normal course of business, we are subject to examination by taxing authorities throughout the world.
Net Sales and Gross Profit Analysis Net sales by segment and percent change for fiscal 2023, fiscal 2022 and fiscal 2021 were as follows ( in thousands ): Net Sales FY 2023 FY 2022 FY 2021 FY23 vs. FY22 % Change FY22 vs.
Net Sales and Gross Profit Analysis Net sales by segment and percent change for fiscal 2024, fiscal 2023 and fiscal 2022 were as follows ( in thousands ): Net Sales FY 2024 FY 2023 FY 2022 FY24 vs. FY23 % Change FY23 vs.
Gross margin as a percentage of net sales increased to 32.0% during fiscal 2022 as compared to 29.0% during fiscal 2021, primarily due to product mix. 24 Canvys Net sales for Canvys increased 11.8% to $39.3 million during fiscal 2023, from $35.2 million during fiscal 2022. Sales increased primarily due to strong sales in the North American market.
Net sales for Canvys increased 11.8% to $39.3 million during fiscal 2023, from $35.2 million during fiscal 2022. Sales increased primarily due to strong sales in the North American market. Gross margin as a percentage of net sales decreased to 31.5% during fiscal 2023 as compared to 32.0% during fiscal 2022 mainly due to product mix.
Net sales by geographic area and percent change for fiscal 2023, fiscal 2022 and fiscal 2021 were as follows ( in thousands ): Net Sales FY 2023 FY 2022 FY 2021 FY23 vs. FY22 % Change FY22 vs.
Net sales by geographic area and percent change for fiscal 2024, fiscal 2023 and fiscal 2022 were as follows ( in thousands ): Net Sales FY 2024 FY 2023 FY 2022 FY24 vs. FY23 % Change FY23 vs.
As of May 27, 2023, a valuation allowance of $1.4 million was recorded, representing the portion of the deferred tax asset that management does not believe is more likely than not to be realized. The valuation allowance as of May 28, 2022 was $3.5 million.
As of June 1, 2024, a valuation allowance of $2.1 million was recorded, representing the portion of the deferred tax asset that management does not believe is more likely than not to be realized. The valuation allowance as of May 27, 2023 was $1.4 million.
Gross margin during fiscal 2023 included expense related to inventory provisions of $0.3 million for PMT, $0.1 million for Canvys and $0.1 million for Healthcare. Consolidated gross profit was $71.7 million during fiscal 2022, compared to $58.8 million during fiscal 2021.
Gross margin during fiscal 2024 included expense related to inventory provisions of $0.4 million for PMT, $0.1 million for Canvys and $0.1 million for Healthcare. Consolidated gross profit was $83.7 million during fiscal 2023, compared to $71.7 million during fiscal 2022.
See Note 8, Income Taxes , of the notes to our consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for further information. Cash, cash equivalents and investments were $40.5 million at May 28, 2022.
See Note 8, Income Taxes , of the notes to our consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for further information. Cash and cash equivalents were $25.0 million at May 27, 2023.
Cash used in financing activities of $0.4 million during fiscal 2022 resulted primarily from the $3.2 million used to pay dividends to shareholders, partially offset by proceeds from the issuance of common stock from stock option exercises. All future payments of dividends are at the discretion of the Board of Directors.
Cash provided by financing activities of $0.4 million during fiscal 2023 resulted primarily from the $3.8 million of proceeds from the issuance of common stock from stock option exercises and the $3.3 million used to pay dividends to shareholders. All future payments of dividends are at the discretion of the Board of Directors.
As of the date of this report, no amounts were outstanding under the Revolving Credit Facility. 28 Cash Flows from Operating Activities Cash flow from operating activities primarily resulted from our net income adjusted for non-cash items and changes in our operating assets and liabilities. Operating activities utilized $8.2 million of cash during fiscal 2023.
As of the end of fiscal 2024 and the date of this report, no amounts were outstanding under the Revolving Credit Facility. Cash Flows from Operating Activities Cash flow from operating activities primarily resulted from our net income adjusted for non-cash items and changes in our operating assets and liabilities. Operating activities provided $6.5 million of cash during fiscal 2024.
Purchasing of future investments may vary from period to period due to interest and foreign currency exchange rates. 29 Cash Flows from Financing Activities The cash flow from financing activities primarily consists of cash dividends paid.
Our purchases and proceeds from investments consist of time deposits and CDs. Purchasing of future investments may vary from period to period due to interest and foreign currency exchange rates. Cash Flows from Financing Activities The cash flow from financing activities primarily consists of cash dividends paid.
We conduct annual reviews for idle and underutilized equipment and review business plans for possible impairment. If adverse events do occur, our impairment review is based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of our assets and liabilities.
If adverse events do occur, our impairment review is based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of our assets and liabilities.
We had net income of $17.9 million during fiscal 2022, which included non-cash stock-based compensation expense of $0.7 million associated with the issuance of stock option awards and restricted stock awards, $0.5 million of inventory provisions, and depreciation and amortization expense of $3.4 million associated with our property and equipment as well as amortization of our intangible assets.
We had net income of $0.1 million during fiscal 2024, which included non-cash stock-based compensation expense of $1.3 million associated with the issuance of stock option awards and restricted stock awards, $0.6 million of inventory provisions and depreciation and amortization expense of $4.3 million associated with our property and equipment as well as amortization of our intangible assets, and a $1.0 million increase in deferred income taxes.
Gross margin during fiscal 2022 included expense related to inventory provisions for PMT of $0.4 million and $0.1 million for Healthcare. Power and Microwave Technologies Net sales for PMT increased 5.7% to $164.3 million during fiscal 2023 from $155.4 million during fiscal 2022.
Gross margin during fiscal 2023 included expense related to inventory provisions of $0.3 million for PMT, $0.1 million for Canvys and $0.1 million for Healthcare. Power and Microwave Technologies Net sales for PMT decreased 21.7% to $128.7 million during fiscal 2024 from $164.3 million during fiscal 2023.
Capital expenditures were primarily related to our LaFox manufacturing business and facility renovation, IT systems and the Healthcare business. Cash used by investing activities of $8.1 million during fiscal 2022 was mainly attributed to the $5.0 million purchase of a Certificate of Deposit (CD) and $3.1 million in capital expenditures.
Cash used by investing activities of $2.2 million during fiscal 2023 was mainly attributed to $7.4 million in capital expenditures with a $5.0 million offset for the maturities of a Certificate of Deposit (CD). Capital expenditures were primarily related to our LaFox manufacturing business and facility renovation, IT systems and the Healthcare business.
Nearly 60% of our products are manufactured in LaFox, Illinois, Marlborough, Massachusetts or Donaueschingen, Germany, or by one of our manufacturing partners throughout the world. All our partners manufacture to our strict specifications and per our supplier code of conduct. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets.
Nearly 55% of our products are manufactured at our facilities located in LaFox, Illinois, Marlborough, Massachusetts and Donaueschingen, Germany, or by one of our manufacturing partners throughout the world. We serve customers in the alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets.
The increase in Healthcare was primarily due to strong part sales and increase in demand for the ALTA750 TM tubes. 23 Gross profit by segment and percent of segment net sales for fiscal 2023, fiscal 2022 and fiscal 2021 were as follows ( in thousands ): Gross Profit FY 2023 FY 2022 FY 2021 PMT $ 54,089 32.9 % $ 50,810 32.7 % $ 43,546 33.8 % GES 13,719 28.8 % 7,231 32.0 % 2,405 29.0 % Canvys 12,375 31.5 % 11,252 32.0 % 10,274 35.0 % Healthcare 3,506 30.7 % 2,407 21.2 % 2,600 25.1 % Total $ 83,689 31.9 % $ 71,700 31.9 % $ 58,825 33.2 % Gross profit reflects the distribution and manufacturing product margin less manufacturing variances, inventory obsolescence charges, customer returns, scrap and cycle count adjustments, engineering costs and other provisions.
The increase in Healthcare was primarily due to an increase in equipment sales. 24 Gross profit by segment and percent of segment net sales for fiscal 2024, fiscal 2023 and fiscal 2022 were as follows ( in thousands ): Gross Profit FY 2024 FY 2023 FY 2022 PMT $ 38,717 30.1 % $ 54,089 32.9 % $ 50,810 32.7 % GES 6,607 28.4 % 13,719 28.8 % 7,231 32.0 % Canvys 10,973 33.8 % 12,375 31.5 % 11,252 32.0 % Healthcare 3,669 30.4 % 3,506 30.7 % 2,407 21.2 % Total $ 59,966 30.5 % $ 83,689 31.9 % $ 71,700 31.9 % Gross profit reflects the distribution and manufacturing product margin less manufacturing variances, inventory obsolescence charges, customer returns, scrap and cycle count adjustments, engineering costs and other provisions.
Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America. Estimates of credit losses are recorded in the financial statements based on monthly reviews of outstanding accounts.
We sell our products to customers in diversified industries and perform periodic credit evaluations of our customers’ financial condition. Terms are generally on open account, payable net 30 days in North America, and vary throughout Asia/Pacific, Europe and Latin America. Estimates of credit losses are recorded in the financial statements based on monthly reviews of outstanding accounts.
We currently have operations in the following major geographic regions: North America, Asia/Pacific, Europe and Latin America. 22 Results of Operations Overview - Fiscal Year Ended May 27, 2023 • Fiscal 2023 and fiscal 2022 both contained 52 weeks. • Net sales during fiscal 2023 were $262.7 million, up 16.9%, compared to net sales of $224.6 million during fiscal 2022. • Gross margin was 31.9% of net sales during fiscal 2023, compared to 31.9% of net sales during fiscal 2022. • Selling, general and administrative expenses were $58.7 million, or 22.4% of net sales, during fiscal 2023, compared to $55.7 million, or 24.8% of net sales, during fiscal 2022. • Operating income during fiscal 2023 was $25.0 million, compared to an operating income of $16.0 million during fiscal 2022. • Other income during fiscal 2023 was less than $0.1 million, compared to other expense of $0.2 million during fiscal 2022. • Net income during fiscal 2023 was $22.3 million, compared to a net income of $17.9 million during fiscal 2022.
We currently operate within the following major geographic regions: North America, Asia/Pacific, Europe and Latin America. 23 Results of Operations Overview - Fiscal Year Ended June 1, 2024 • Fiscal 2024 contained 53 weeks and fiscal 2023 contained 52 weeks. • Net sales during fiscal 2024 were $196.5 million, down 25.2%, compared to net sales of $262.7 million during fiscal 2023. • Gross margin was 30.5% of net sales during fiscal 2024, compared to 31.9% of net sales during fiscal 2023. • Selling, general and administrative expenses were $59.5 million, or 30.3% of net sales, during fiscal 2024, compared to $58.7 million, or 22.4% of net sales, during fiscal 2023. • Operating income during fiscal 2024 was $0.3 million, compared to an operating income of $25.0 million during fiscal 2023. • Other expense during fiscal 2024 was $0.2 million, compared to other income of less than $0.1 million during fiscal 2023. • Net income during fiscal 2024 was $0.1 million, compared to a net income of $22.3 million during fiscal 2023.
Consolidated gross profit was $83.7 million during fiscal 2023, compared to $71.7 million during fiscal 2022.
Consolidated gross profit was $60.0 million during fiscal 2024, compared to $83.7 million during fiscal 2023.
SG&A as a percentage of sales decreased to 22.4% during fiscal 2023 as compared to 24.8% during fiscal 2022. Selling, general and administrative expenses decreased during fiscal 2022 to $55.7 million from $55.9 million during fiscal 2021.
SG&A as a percentage of sales increased to 30.3% during fiscal 2024 as compared to 22.4% during fiscal 2023. Selling, general and administrative expenses increased during fiscal 2023 to $58.7 million from $55.7 million during fiscal 2022.
PMT also offers its customers technical services for both microwave and industrial equipment. Green Energy Solutions combines our key technology partners and engineered solutions capabilities to design and manufacture innovative products for the fast-growing energy storage market and power management applications.
Green Energy Solutions ("GES") combines our key technology partners and engineered solutions capabilities to design and manufacture innovative products for the fast-growing energy storage market and power management applications.
These additional tariffs are a response to what the USTR considers to be certain unfair trade practices by China. A number of the Company's products manufactured in China are now subject to these additional duties of 25% when imported into the United States.
Some of the Company's products are manufactured in China and imported into the United States. The Office of the United States Trade Representative ("USTR") instituted tariffs on the importation of a number of products into the United States from China. These tariffs are a response to what the USTR considers to be certain unfair trade practices by China.
Although the Tax Cuts and Jobs Act generally eliminated federal income tax on future cash repatriation to the United States, cash repatriation may be subject to state and local taxes, withholding or similar taxes.
We repatriated $0.3 million to the United States in the second quarter of fiscal 2024 from our entity in Mexico. Although the Tax Cuts and Jobs Act generally eliminated federal income tax on future cash repatriation to the United States, cash repatriation may be subject to state and local taxes, withholding or similar taxes.
Fiscal 2023 had $0.3 million of investment income compared to $0.1 million of investment income for fiscal 2022. Our foreign exchange gains and losses are primarily due to the translation of U.S. dollars held in non-U.S. entities. The foreign exchange loss reported for fiscal 2023 totaled $0.3 million, unchanged from fiscal 2022.
Other Income/Expense Other expense was $0.2 million during fiscal 2024, compared to other income of less than $0.1 million during fiscal 2023. Fiscal 2024 had $0.3 million of investment income the same as fiscal 2023. Our foreign exchange gains and losses are primarily due to the translation of U.S. dollars held in non-U.S. entities.
We currently do not utilize derivative instruments to manage our exposure to foreign currency. Income Tax Provision Our income tax provision (benefit) during fiscal 2023, fiscal 2022 and fiscal 2021 was $2.7 million, ($2.2 million) and $0.7 million, respectively. The effective income tax rates during fiscal 2023, fiscal 2022 and fiscal 2021 were 10.8%, (13.7%) and 28.3%, respectively.
The foreign exchange loss reported for fiscal 2024 totaled $0.4 million compared to $0.3 million for fiscal 2023. We currently do not utilize derivative instruments to manage our exposure to foreign currency. Income Tax Provision Our income tax provision (benefit) during fiscal 2024, fiscal 2023 and fiscal 2022 was $0.1 million, $2.7 million and ($2.2 million), respectively.
As a designer, manufacturer, technology partner and authorized distributor, GES’s strategy is to provide specialized technical expertise and engineered solutions using our core design engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure.
As a designer, manufacturer, technology partner and authorized distributor, GES’s strategy is to provide specialized technical expertise and engineered solutions using our core design engineering and manufacturing capabilities on a global basis.
The majority of the inventory increase was to support our Electron tube, PMG, Green Energy Solutions, LaFox manufacturing and Healthcare businesses. The decrease in accounts payable and accrued liabilities was due to revenue recognition and timing. Operating activities provided $1.9 million of cash during fiscal 2022.
The majority of the inventory increase was to support our Electron tube, PMG, Green Energy Solutions, LaFox manufacturing and Healthcare businesses. The decrease in accounts payable and accrued liabilities was due to revenue recognition and timing. 29 Cash Flows from Investing Activities The cash flow from investing activities consisted primarily of purchases and maturities of investments and capital expenditures.
As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis. We provide solutions and add value through design-in support, systems integration, prototype design and manufacturing, testing, logistics and aftermarket technical service and repair—all through our existing global infrastructure.
As a designer, manufacturer, technology partner and authorized distributor, PMT’s strategy is to provide specialized technical expertise and engineered solutions based on our core engineering and manufacturing capabilities on a global basis.
Proceeds of the borrowings under the Revolving Credit Facility are expected to be used for working capital and general corporate purposes of the Company and its subsidiaries.
Proceeds of the borrowings under the Revolving Credit Facility are expected to be used for working capital and general corporate purposes of the Company and its subsidiaries. The Company utilized $3.7 million of the credit line to address short-term cash requirements and repaid that $3.7 million during the fiscal 2024.
Net deferred tax assets related to foreign NOL carryforwards was $0.2 million as of May 27, 2023 compared to $0.4 million as of May 28, 2022, with various or indefinite expiration dates. We released the valuation allowance and have utilized $1.8 million of domestic net deferred tax asset related to foreign tax credit carryforwards as of May 27, 2023.
Net deferred tax assets related to foreign NOL carryforwards was $0.1 million as of June 1, 2024, and $0.2 million as of May 27, 2023 with various or indefinite expiration dates.
PMT’s focus is on products for power, RF and microwave applications for customers in 5G, aviation, broadcast, communications, industrial, marine, medical, military, scientific and semiconductor markets. PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology.
PMT focuses on various applications including broadcast transmission, CO2 laser cutting, diagnostic imaging, dielectric and induction heating, high energy transfer, high voltage switching, plasma, power conversion, radar and radiation oncology. PMT also offers its customers technical services for both microwave and industrial equipment.
Selling, General and Administrative Expenses Selling, general and administrative expenses (“SG&A”) increased during fiscal 2023 to $58.7 million from $55.7 million during fiscal 2022. This increase in SG&A expense from fiscal 2022 was mainly due to higher employee compensation and travel expenses, partially offset by lower legal fees and a lower bad debt expense.
Selling, General and Administrative Expenses Selling, general and administrative expenses (“SG&A”) increased 1.4% during fiscal 2024 to $59.5 million from $58.7 million during fiscal 2023. This increase in SG&A from fiscal 2023 was mainly due to higher R&D expenses, partially offset by lower incentives due to financial performance.
Cash provided by financing activities of $0.4 million during fiscal 2023 resulted primarily from the $3.8 million of proceeds from the issuance of common stock from stock option exercises and the $3.3 million used to pay dividends to shareholders.
Cash used in financing activities of $2.9 million during fiscal 2024 resulted primarily from the $3.4 million used to pay dividends to shareholders with a $0.6 million offset for the proceeds from stock option exercises.
The weight of this positive evidence is sufficient to outweigh other negative evidence in evaluating our need for a valuation allowance in the U.S. federal jurisdiction. As a result of the positive evidence outweighing the negative evidence for the year ended May 28, 2022, we released the full valuation allowance on the U.S. federal and state deferred tax items.
The weight of this positive evidence is sufficient to outweigh other negative evidence in evaluating our need for a valuation allowance in the U.S. federal jurisdiction.
The slight increase in sales was primarily due to an increase in equipment sales, partially offset by decreases in part sales and CT tube sales. Gross margin as a percentage of net sales increased to 30.7% during fiscal 2023, compared to 21.2% during fiscal 2022. The increase was primarily due to improved manufacturing absorption and decreased component scrap expenses.
Gross margin as a percentage of net sales increased to 30.7% during fiscal 2023, compared to 21.2% during fiscal 2022. The increase was primarily due to improved manufacturing absorption and decreased component scrap expenses. Sales by Geographic Area Our sales are aggregated by the following geographic regions: North America; Asia/Pacific; Europe; Latin America; and Other.
Sales for PMT increased by 5.7%, GES sales increased by 110.5%. Canvys sales increased by 11.8% and Healthcare sales increased by 0.5%. The increase in PMT was mainly due to strong growth in the semi-wafer fabrication industry and the RF and microwave products for various applications.
Sales for PMT decreased by 21.7%, GES sales decreased by 51.2%, Canvys sales decreased by 17.5% and Healthcare sales increased by 5.7%. The decrease in PMT was mainly due to lower sales of semi-wafer fabrication products and RF and microwave products.
FY21 % Change PMT $ 164,299 $ 155,445 $ 128,980 5.7 % 20.5 % GES 47,596 22,611 8,300 110.5 % 172.4 % Canvys 39,331 35,187 29,319 11.8 % 20.0 % Healthcare 11,432 11,377 10,338 0.5 % 10.1 % Total $ 262,658 $ 224,620 $ 176,937 16.9 % 26.9 % During fiscal 2023, consolidated net sales increased by 16.9% compared to fiscal 2022.
FY22 % Change PMT $ 128,697 $ 164,299 $ 155,445 (21.7 %) 5.7 % GES 23,233 47,596 22,611 (51.2 %) 110.5 % Canvys 32,444 39,331 35,187 (17.5 %) 11.8 % Healthcare 12,086 11,432 11,377 5.7 % 0.5 % Total $ 196,460 $ 262,658 $ 224,620 (25.2 %) 16.9 % During fiscal 2024, consolidated net sales decreased by 25.2% compared to fiscal 2023.
Consolidated gross margin as a percentage of net sales decreased to 31.9% during fiscal 2022, from 33.2% during fiscal 2021, primarily due to unfavorable product mix for PMT, favorable product mix for GES, higher freight costs and foreign exchange effects for Canvys and increased component scrap expenses for Healthcare.
Consolidated gross margin as a percentage of net sales was 30.5% for fiscal 2024, compared to the 31.9% during fiscal 2023, primarily due to unfavorable product mix and manufacturing under absorption for PMT, unfavorable product mix for GES, favorable product mix and lower freight costs for Canvys and increased manufacturing under absorption for Healthcare.
Management continues to work with its suppliers as well as its customers to mitigate the impact of the tariffs on our customers’ markets.
A number of the Company's products manufactured in China are subject to duties of 25% when imported into the United States. Management continues to work with its suppliers as well as its customers to mitigate the impact of the tariffs on our customers’ markets.
Gross margin as a percentage of net sales decreased to 31.5% during fiscal 2023 as compared to 32.0% during fiscal 2022 mainly due to product mix. Net sales for Canvys increased 20.0% to $35.2 million during fiscal 2022, from $29.3 million during fiscal 2021. Sales increased primarily due to strong sales in the European and North American markets.
Gross margin as a percentage of net sales decreased to 28.8% during fiscal 2023 as compared to 32.0% during fiscal 2022, primarily due to product mix. 25 Canvys Net sales for Canvys decreased 17.5% to $32.4 million during fiscal 2024, from $39.3 million during fiscal 2023.
Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models. We review property and equipment, definite-lived intangible assets and other long-lived assets for impairment whenever adverse events or changes in circumstances indicate that the carrying amounts of such assets may not be recoverable.
We review property and equipment, definite-lived intangible assets and other long-lived assets for impairment whenever adverse events or changes in circumstances indicate that the carrying amounts of such assets may not be recoverable. We conduct annual reviews for idle and underutilized equipment and review business plans for possible impairment.
However, if the Company is unable to successfully pass through the additional cost of these tariffs, or if the higher prices reduce demand for the Company's products, it will have a negative effect on the Company's sales and gross margins.
However, if the Company is unable to successfully pass through the additional cost of these tariffs, or if the higher prices reduce demand for the Company's products, it will have a negative effect on the Company's sales and gross margins. 22 The Company reports its financial performance based on the operating and reportable segments defined as follows: Power and Microwave Technologies ("PMT") combines our core engineered solutions capabilities, power grid and microwave tube business with new disruptive RF, Wireless and Power technologies.
We record penalties and interest related to uncertain tax positions in the income tax expense line item within the Consolidated Statements of Comprehensive Income. Accrued interest and penalties were included within the related tax liability line in the Consolidated Balance Sheets. We have not recorded a liability for interest and penalties as of May 27, 2023 or May 28, 2022.
The Company recorded a $0.1 million uncertain tax position as of June 1, 2024 as compared to not recording an uncertain tax position as of May 27, 2023. We record interest related to uncertain tax positions in the income tax expense line item within the Consolidated Statements of Comprehensive Income.
The deferred tax liability related to undistributed earnings of our foreign subsidiaries was less than $0.1 million in both fiscal 2023 and fiscal 2022. Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to support a more likely than not assertion that its deferred tax assets will be realized.
Management assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to support a more likely than not assertion that its deferred tax assets will be realized. A significant component of objective evidence evaluated was the cumulative income or loss incurred in each jurisdiction over the three-year period ended June 1, 2024.
The increase in GES was primarily due to growth in related product sales to the wind turbine industry, as well as EV battery modules. The increase in Canvys was primarily due to strong sales in the North American market. The increase in Healthcare was primarily due to an increase in equipment sales.
The increase in PMT was mainly due to strong growth in the semi-wafer fabrication industry and the RF and microwave products for various applications. The increase in GES was primarily due to growth in related product sales to the wind turbine industry, as well as EV battery modules.
In addition, the Company recognized both foreign tax and research and development tax credits in fiscal 2023.
In addition, the Company recognized both foreign tax and research and development ("R&D") tax credits in fiscal 2024. During the fourth quarter of fiscal 2024, the Company recorded R&D tax credits of $0.5 million.
Net sales for Healthcare increased 10.1% to $11.4 million during fiscal 2022, from $10.3 million during fiscal 2021. The increase in sales was primarily due to strong parts sales and an increase in demand for the ALTA 750D TM tubes. Gross margin as a percentage of net sales decreased to 21.2% during fiscal 2022, compared to 25.1% during fiscal 2021.
Healthcare Net sales for Healthcare increased 5.7% to $12.1 million during fiscal 2024, from $11.4 during fiscal 2023. The increase in sales was primarily due to higher part and CT tube sales. Gross margin as a percentage of net sales decreased slightly to 30.4% during fiscal 2024, compared to 30.7% during fiscal 2023.
Generally, years prior to fiscal 2017 are closed for examination under the statute of limitation for U.S. federal, U.S. state and local or non-U.S. tax jurisdictions. We were under examination for fiscal 2015 through fiscal 2018 in Germany. The audit was settled in the fourth quarter of fiscal 2022.
Years prior to fiscal 2015 are closed for examination under the statute of limitation for U.S. federal and U.S. state. In the Netherlands, years prior to fiscal 2019 are closed for examination. We are under examination in Germany for fiscal years 2019 to 2022. We have no current open audits in the U.S.
The increase was mainly due to growth in related product sales to the wind turbine industry, as well as EV battery modules. Gross margin as a percentage of net sales decreased to 28.8% during fiscal 2023 as compared to 32.0% during fiscal 2022, primarily due to product mix.
Net sales for GES increased 110.5% to $47.6 million during fiscal 2023 from $22.6 million during fiscal 2022. The increase was mainly due to growth in related product sales to the wind turbine industry, as well as EV battery modules.
Critical Accounting Policies and Estimates The preparation of financial statements in conformity with United States Generally Accepted Accounting Principles (“GAAP”) and pursuant to the rules and regulations of the SEC, we make assumptions, judgments and estimates that affect the reported amounts of assets, liabilities, revenue and expenses and the related disclosures of contingent assets and liabilities.
Contractual Obligations Contractual obligations are presented in the table below as of June 1, 2024 ( in thousands ): Less than 1 year 1 - 3 years 4 - 5 years More than 5 years Less Interest Total Lease obligations (1) $ 1,294 $ 1,505 $ 142 $ — $ (181 ) $ 2,760 (1) Lease obligations are related to certain warehouse and office facilities under non-cancelable operating leases as well as financing leases. 30 Critical Accounting Estimates The preparation of financial statements in conformity with United States Generally Accepted Accounting Principles (“GAAP”) and pursuant to the rules and regulations of the SEC, we make assumptions, judgments and estimates that affect the reported amounts of assets, liabilities, revenue and expenses and the related disclosures of contingent assets and liabilities.
Changes in our operating assets and liabilities resulted in a use of cash of $16.5 million during fiscal 2022, primarily due to the increase in inventories of $20.6 million, an increase in accounts receivable of $6.2 million and an increase in prepaid expenses of $0.2 million.
Changes in our operating assets and liabilities provided cash of $1.2 million during fiscal 2024, mainly due to a decrease in receivables of $5.3 million, a decrease in accounts payable and accrued liabilities of $4.7 million and a decrease in prepaid expenses of $0.3 million.
The increase in GES was primarily due to components for power management applications and niche products for wind turbines. The increase in Canvys was primarily due to strong sales in the European and North American markets.
The increase in Canvys was primarily due to strong sales in the North American market.
We have historically determined that undistributed earnings of our foreign subsidiaries, to the extent of cash available, will be repatriated to the U.S. The deferred tax liability on the outside basis difference is now primarily withholding tax on future dividend distributions.
The deferred tax liability on the outside basis difference is now primarily withholding tax on future dividend distributions. The deferred tax liability related to undistributed earnings of our foreign subsidiaries was less than $0.1 million in both fiscal 2024 and fiscal 2023.
During fiscal 2022, consolidated net sales increased by 26.9% compared to fiscal 2021. Sales for PMT increased by 20.5%, GES sales increased by 172.4%, Canvys sales increased by 20.0% and Healthcare sales increased by 10.1%.
The increase in Healthcare was primarily due to higher part and CT tube sales. During fiscal 2023, consolidated net sales increased by 16.9% compared to fiscal 2022. Sales for PMT increased by 5.7%, GES sales increased by 110.5%, Canvys sales increased by 11.8% and Healthcare sales increased by 0.5%.
If future demand changes in an industry or market conditions differ from management’s estimates, additional provisions may be necessary. 31 Intangible and Long-Lived Assets Our intangible assets represent the fair value for trade name, customer relationships, non-compete agreements and technology acquired in connection with the acquisitions.
If future demand changes in an industry or market conditions differ from management’s estimates, additional provisions may be necessary. Intangible and Long-Lived Assets Our intangible assets reflect their fair value. Intangible assets are initially recorded at their fair market values determined by quoted market prices in active markets, if available, or recognized valuation models.
However, when considering the non-recurrence of the $1.6 million legal settlement in fiscal 2021, the SG&A expense for fiscal 2022 was $1.4 million or 2.6% higher than fiscal 2021. This increase in SG&A expense from fiscal 2021 was mainly due to higher employee compensation expenses including incentive expense, partially offset by lower legal fees.
This increase in SG&A expense from fiscal 2022 was mainly due to higher employee compensation and travel expenses, partially offset by lower legal fees and a lower bad debt expense. SG&A as a percentage of sales decreased to 22.4% during fiscal 2023 as compared to 24.8% during fiscal 2022.
As of May 27, 2023 and May 28, 2022 we have utilized all net deferred tax assets related to federal net operating loss (“NOL”) carryforwards. Net deferred tax assets related to domestic state NOL carryforwards at May 27, 2023 amounted to approximately $2.1 million, compared to $2.4 million at May 28, 2022.
These credits represent the expected U.S. federal credits to be claimed for fiscal 2024. 27 Net deferred tax assets related to domestic state NOL carryforwards at June 1, 2024 amounted to approximately $1.8 million, compared to $2.1 million at May 27, 2023.
Cash, cash equivalents and investments by geographic area at May 28, 2022 consisted of $25.7 million in North America, $6.0 million in Europe, $1.5 million in Latin America and $7.3 million in Asia/Pacific. We repatriated a total of $1.5 million to the United States in fiscal 2022 from our foreign entities.
Cash and cash equivalents were $24.3 million at June 1, 2024. Cash and cash equivalents by geographic area at June 1, 2024 consisted of $7.1 million in North America, $7.3 million in Europe, $1.1 million in Latin America and $8.8 million in Asia/Pacific.
We also had strong growth in various Electron Device (EDG) product lines. Gross margin as a percentage of net sales decreased to 32.7% during fiscal 2022 as compared to 33.8% during fiscal 2021, primarily due to product mix. Green Energy Solutions Net sales for GES increased 110.5% to $47.6 million during fiscal 2023 from $22.6 million during fiscal 2022.
Gross margin as a percentage of net sales decreased to 30.1% during fiscal 2024 as compared to 32.9% during fiscal 2023, primarily due to unfavorable product mix and manufacturing under absorption. Net sales for PMT increased 5.7% to $164.3 million during fiscal 2023 from $155.4 million during fiscal 2022.
This analysis requires management judgment with respect to changes in technology, the continued success of product lines and future volume, revenue and expense growth rates. Loss Contingencies We accrue a liability for loss contingencies when it is probable that a liability has been incurred and the amount can be reasonably estimated.
This analysis requires management judgment with respect to changes in technology, the continued success of product lines and future volume, revenue and expense growth rates. Income Taxes We recognize deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities.
Liquidity, Financial Position and Capital Resources Our operations and cash needs have been primarily financed through income from operations and cash on hand. Cash and cash equivalents were $25.0 million at May 27, 2023.
Accrued interest was included within the related tax liability line in the Consolidated Balance Sheets. We have recorded a liability of less than $0.1 million for interest as of June 1, 2024. 28 Liquidity, Financial Position and Capital Resources Our operations and cash needs have been primarily financed through income from operations and cash on hand.
Gross margin as a percentage of net sales decreased to 32.0% during fiscal 2022 as compared to 35.0% during fiscal 2021 mainly due to increasing freight costs resulting from the COVID-19 pandemic and foreign currency effects. Healthcare Net sales for Healthcare increased 0.5% to $11.4 million during fiscal 2023, essentially unchanged from fiscal 2022.
Sales decreased primarily due to lower sales in the North American market resulting from high interest rates negatively impacting our medical OEM customers. Gross margin as a percentage of net sales increased to 33.8% during fiscal 2024 as compared to 31.5% during fiscal 2023 due to product mix and lower freight costs.